BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37596850)

  • 1. Increased expression of autophagy-related gene 5 indicates poor prognosis in patients with hepatocellular carcinoma.
    Guo HY; Yu XN; Zhang GC; Yin J; Dong L; Liu TT; Qian ZP; Zhu JM; Shen XZ
    J Dig Dis; 2023; 24(6-7):399-407. PubMed ID: 37596850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced mLST8 Expression Correlates with Tumor Progression in Hepatocellular Carcinoma.
    Yu XN; Zhang GC; Sun JL; Zhu HR; Shi X; Song GQ; Weng SQ; Dong L; Liu TT; Shen XZ; Guo HY; Zhu JM
    Ann Surg Oncol; 2020 May; 27(5):1546-1557. PubMed ID: 32157528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nomograms to Predict the Disease-free Survival and Overall Survival after Radiofrequency Ablation for Hepatocellular Carcinoma.
    Takuma Y; Shota I; Miyatake H; Uematsu S; Okamoto R; Araki Y; Takabatake H; Morimoto Y; Yamamoto H
    Intern Med; 2018 Feb; 57(4):457-468. PubMed ID: 29151504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of prognostic nomograms in patients with hepatocellular carcinoma: a population-based study.
    Zang Y; Long P; Wang M; Huang S; Chen C
    Future Oncol; 2021 Dec; 17(36):5053-5066. PubMed ID: 34676798
    [No Abstract]   [Full Text] [Related]  

  • 5. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma.
    Zhu PP; Yuan SG; Liao Y; Qin LL; Liao WJ
    World J Gastroenterol; 2015 Jun; 21(23):7254-63. PubMed ID: 26109813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of ULK1 and LC3B improve prognosis assessment of hepatocellular carcinoma.
    Wu DH; Wang TT; Ruan DY; Li X; Chen ZH; Wen JY; Lin Q; Ma XK; Wu XY; Jia CC
    Biomed Pharmacother; 2018 Jan; 97():195-202. PubMed ID: 29091866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of autophagy defect with a malignant phenotype and poor prognosis of hepatocellular carcinoma.
    Ding ZB; Shi YH; Zhou J; Qiu SJ; Xu Y; Dai Z; Shi GM; Wang XY; Ke AW; Wu B; Fan J
    Cancer Res; 2008 Nov; 68(22):9167-75. PubMed ID: 19010888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA-ATB promotes autophagy by activating Yes-associated protein and inducing autophagy-related protein 5 expression in hepatocellular carcinoma.
    Wang CZ; Yan GX; Dong DS; Xin H; Liu ZY
    World J Gastroenterol; 2019 Sep; 25(35):5310-5322. PubMed ID: 31558875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low expression of organic anion-transporting polypeptide 1B3 predicts a poor prognosis in hepatocellular carcinoma.
    Chen S; Li K; Jiang J; Wang X; Chai Y; Zhang C; Deng Q; Shuai L; Feng K; Ma K; Zhang L
    World J Surg Oncol; 2020 Jun; 18(1):127. PubMed ID: 32534581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Nomograms Stratify Survival of Patients with Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis After Curative Resection.
    Fu YP; Yi Y; Huang JL; Jing CY; Sun J; Ni XC; Lu ZF; Cao Y; Zhou J; Fan J; Qiu SJ
    Oncologist; 2017 May; 22(5):561-569. PubMed ID: 28438885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel prognostic nomogram based on microvascular invasion and hematological biomarkers to predict survival outcome for hepatocellular carcinoma patients.
    Li X; Huang H; Yu X; Chen P; Ouyang J; Huang B
    Surg Oncol; 2020 Jun; 33():51-57. PubMed ID: 32561099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of HOXA13 as a potential marker for diagnosis and poor prognosis of hepatocellular carcinoma.
    Pan TT; Jia WD; Yao QY; Sun QK; Ren WH; Huang M; Ma J; Li JS; Ma JL; Yu JH; Ge YS; Liu WB; Zhang CH; Xu GL
    Tohoku J Exp Med; 2014 Nov; 234(3):209-19. PubMed ID: 25341685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Protease-Activated Receptor 2 in Hepatocellular Carcinoma after Hepatectomy.
    Tsai MC; Lin CC; Chen DW; Liu YW; Wu YJ; Yen YH; Huang PY; Yao CC; Chuang CH; Hsiao CC
    Medicina (Kaunas); 2021 Jun; 57(6):. PubMed ID: 34199695
    [No Abstract]   [Full Text] [Related]  

  • 16. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SNRPD1 inhibition suppresses the proliferation of hepatocellular carcinoma and promotes autophagy through the PI3K/AKT/mTOR/4EBP1 pathway.
    Wang H; Chen M; Yang C; Hu H; Jiang Y; Yang F; Lv L
    Arch Biochem Biophys; 2023 Jul; 743():109661. PubMed ID: 37268273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulated calcium-binding tyrosine phosphorylation-regulated protein-a/b regulates cell proliferation and apoptosis and predicts poor prognosis in hepatocellular carcinoma.
    Yu XN; Guo HY; Liu TT; Zhang GC; Zhu HR; Shi X; Song GQ; Jiang XM; Huang XX; Weng SQ; Dong L; Shen XZ; Huang YQ; Zhu JM
    J Cell Biochem; 2020 Apr; 121(4):2938-2949. PubMed ID: 31692072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
    Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
    Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
    [No Abstract]   [Full Text] [Related]  

  • 20. A model prediction of long-term prognosis in patients with centrally located hepatocellular carcinoma undergoing hepatectomy.
    Yantong Y; Shan L; Zhijie C; Youwei Z
    Eur J Surg Oncol; 2018 Oct; 44(10):1595-1602. PubMed ID: 30041973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.